Relationship between coronary events and serum cholesterol during 10 years of low-dose simvastatin therapy - long-term efficacy and safety in Japanese patients with hypercholesterolemia in the Japan lipid intervention trial (J-LIT) extension 10 study, a prospective large-scale observational cohort study

Circulation Journal

Volumn 72, Issue 8, 2008, Pages 1218-1224

  Itakura, Hiroshige ^a,k   Kita, Toru ^b   Mabuchi, Hiroshi ^c   Matsuzaki, Masunori ^d   Matsuzawa, Yuji ^e   Nakaya, Noriaki ^f   Oikawa, Shinichi ^g   Saito, Yasushi ^h   Sasaki, Jun ⁱ   Shimamoto, Kazuaki ^j  

^a IBARAKI CHRISTIAN UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SUMITOMO HOSPITAL   (Japan)

^f Nakaya Clinic   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h CHIBA UNIVERSITY   (Japan)

ⁱ INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^j SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k Central Executive Committee   (Japan)

more..

Author keywords

Cholesterol lowering therapy; Coronary heart disease; Efficacy; Safety; Simvastatin

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY RISK; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; JAPANESE; KIDNEY DISEASE; LABORATORY TEST; LIVER DISEASE; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; RHABDOMYOLYSIS; SIDE EFFECT; SKIN DISEASE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIMVASTATIN; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 48749121395     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.1218     Document Type: Article

References (17)

1. Matsuzawa Y, Itakura H, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, et al and the J-LIT Study Group. Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: The Japan Lipid Intervention Trial (J-LJT). Curr Ther Res 2000; 61: 219-243.
2. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, et al and the J-LIT Study Group. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66: 1087-1095.
3. Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, et al and the J-LJT Study Group. Large-scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease. Circ J 2002; 66: 1096-1100.
4. Matsuzawa Y, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, Oikawa S, et al and the J-LJT Study Group. Sustained reduction of semm cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients. Circ J 2003; 67: 287-294.
5. Nakaya N, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Oikawa S, et al and the J-LIT Study Group. Large-scale cohort study on the relationship between semm lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia. Circ J 2005; 69: 1016-1021.
6. Oikawa S, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, et al. Jiisk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy; Implication from Japan Lipid Intervention Trial (J-LIT). Atherosclerosis 2007; 191: 440-446.
7. Shimamoto K, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, et al. The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia; Sub-analysis of the Japan Lipid Intervention Trial (J-LJT) Study, a large-scale observational cohort study. Hypertens Res 2005; 28: 879-887.
8. Shimamoto K, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, et al. Effects of hypertension and type 2 diabetes mellitus on the risk of total cardiovascular events in Japanese patients with hypercholesterolemia: Implications from the Japan Lipid Istervention Trial. Hypertens Res 2007; 30: 119-123.
9. Pedersen TR, Wilhelmsen L, Faergeman O, Strandberg TE, Thorgeirsson G, Troedsson L, et al. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
10. Todd PA, Goa KL. Simvastatin: A review of its pharmacological properties and therapeutic potential in hypercholesterolemia. Drugs 1990;40:583-587.
11. Chrisholm A, Mann J, Sutherland W, Williams S, Ball M. Dietary management of patients with familial hypercholesterolemia treated with simvastatin. Q J Med 1992; 85: 825-831.
12. Clifton PM, Noakes M, Nestel PJ. Gender and diet interactions with simvastatin treatment. Atherosclerosis 1994; 110: 25-33.
13. Mantel-Teeuwisse AK, Goettsch WG, Klungel OH, de Boer A, Herings RMC. Long term persistence with statin treatment in daily medical practice. Heart 2004; 90: 1065-1066.
14. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288: 455-461.
15. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462-467.
16. Nagashima H, Kasanuki IT. The status of lipid management in 1,836 patients with coronary artery disease: A multicenter survey to evaluate the percentage of Japanese coronary artery disease patients achieving the target low-density lipoprotein cholesterol level specified by the Japan Atherosclerosis Society. J Atheroscler Thromb 2005; 12: 338-342.
17. Saito Y. JAS Guideline and statin treatment. J Atheroscler Thromb 2005; 12: 343.